Welcome to Peptide Card of AntiTbPdb
| This page displays user query in tabular form. |
PLLKKLLKKP details |
| Primary information | |
|---|---|
| ID | antitb_1617, |
| Name | 26380930 |
| N-Terminal modification | PP |
| C-Terminal Modification | PLLKKLLKKP |
| Chemical Modification | Free |
| Linear/Cyclic | Amidation |
| Length | None |
| Chirality | Linear |
| Nature | 10 |
| Source | L |
| Origin | Cationic |
| Species | Synthetic |
| Inhibition Concentration | Mycobacterium smegmatis |
| In Vitro/ In vivo | Mycobacterium smegmatis ATCC14468 |
| Cell Line | MIC = 250 μg/ml |
| Inhibition Concentration | in vitro |
| Sequence | 2015 |
| Cytotoxicity | RAW 264.7 mouse macrophage |
| In vivo Model | NA |
| Lethal Dose | HC50= >500 μg/ml |
| Immune Responce | NA |
| Mechanism of Action | NA |
| Target | NA |
| Combination Therapy | Bacterial membrane pore formation |
| Other activities | NA |
| PMID | NA |
| Year of Publication | NA |
| Tertiary Structure (Technique) | Not Predicted), |
| Primary information | |
|---|---|
| ID | antitb_1623, |
| Name | 26380930 |
| N-Terminal modification | PP |
| C-Terminal Modification | PLLKKLLKKP |
| Chemical Modification | Free |
| Linear/Cyclic | Amidation |
| Length | None |
| Chirality | Linear |
| Nature | 10 |
| Source | L |
| Origin | Cationic |
| Species | Synthetic |
| Inhibition Concentration | Mycobacterium smegmatis |
| In Vitro/ In vivo | Mycobacterium smegmatis ATCC14468 |
| Cell Line | MIC = 125 μg/ml |
| Inhibition Concentration | in vitro |
| Sequence | 2015 |
| Cytotoxicity | RAW 264.7 mouse macrophage |
| In vivo Model | NA |
| Lethal Dose | HC50= >500 μg/ml |
| Immune Responce | NA |
| Mechanism of Action | NA |
| Target | NA |
| Combination Therapy | Bacterial membrane pore formation |
| Other activities | NA |
| PMID | Peptide + Rifampicin (0.98 μg/ml) |
| Year of Publication | NA |
| Tertiary Structure (Technique) | Not Predicted), |